Annual D&A
$1.01 M
+$62.00 K+6.57%
31 December 2023
Summary:
Zevra Therapeutics annual depreciation & amortization is currently $1.01 million, with the most recent change of +$62.00 thousand (+6.57%) on 31 December 2023. During the last 3 years, it has risen by +$733.00 thousand (+268.50%). ZVRA annual D&A is now at all-time high.ZVRA Depreciation And Amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly D&A
$1.62 M
+$55.00 K+3.52%
30 September 2024
Summary:
Zevra Therapeutics quarterly depreciation & amortization is currently $1.62 million, with the most recent change of +$55.00 thousand (+3.52%) on 30 September 2024. Over the past year, it has increased by +$1.55 million (+2508.06%). ZVRA quarterly D&A is now at all-time high.ZVRA Quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM D&A
$5.53 M
+$1.55 M+39.14%
30 September 2024
Summary:
Zevra Therapeutics TTM depreciation & amortization is currently $5.53 million, with the most recent change of +$1.55 million (+39.14%) on 30 September 2024. Over the past year, it has increased by +$5.01 million (+965.13%). ZVRA TTM D&A is now at all-time high.ZVRA TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ZVRA Depreciation And Amortization Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +6.6% | +2508.1% | +965.1% |
| 3 y3 years | +268.5% | +2387.7% | +2034.4% |
| 5 y5 years | +210.5% | +2027.6% | +1694.8% |
ZVRA Depreciation And Amortization High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +291.4% | at high | +2508.1% | at high | +2051.0% |
| 5 y | 5 years | at high | +291.4% | at high | +2508.1% | at high | +2051.0% |
| alltime | all time | at high | +1379.4% | at high | +8883.3% | at high | >+9999.0% |
Zevra Therapeutics Depreciation And Amortization History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $1.62 M(+3.5%) | $5.53 M(+39.1%) |
| June 2024 | - | $1.56 M(0.0%) | $3.97 M(+59.6%) |
| Mar 2024 | - | $1.56 M(+98.5%) | $2.49 M(+147.4%) |
| Dec 2023 | $1.01 M(+6.6%) | $787.00 K(+1169.4%) | $1.01 M(+93.8%) |
| Sept 2023 | - | $62.00 K(-20.5%) | $519.00 K(-39.3%) |
| June 2023 | - | $78.00 K(-1.3%) | $855.00 K(-10.8%) |
| Mar 2023 | - | $79.00 K(-73.7%) | $958.00 K(+1.5%) |
| Dec 2022 | $944.00 K(+267.3%) | $300.00 K(-24.6%) | $944.00 K(+33.3%) |
| Sept 2022 | - | $398.00 K(+119.9%) | $708.00 K(+88.8%) |
| June 2022 | - | $181.00 K(+178.5%) | $375.00 K(+45.3%) |
| Mar 2022 | - | $65.00 K(+1.6%) | $258.00 K(+0.4%) |
| Dec 2021 | $257.00 K(-5.9%) | - | - |
| Dec 2021 | - | $64.00 K(-1.5%) | $257.00 K(-0.8%) |
| Sept 2021 | - | $65.00 K(+1.6%) | $259.00 K(-0.8%) |
| June 2021 | - | $64.00 K(0.0%) | $261.00 K(-1.5%) |
| Mar 2021 | - | $64.00 K(-3.0%) | $265.00 K(-2.9%) |
| Dec 2020 | $273.00 K(-10.2%) | $66.00 K(-1.5%) | $273.00 K(-3.2%) |
| Sept 2020 | - | $67.00 K(-1.5%) | $282.00 K(-3.1%) |
| June 2020 | - | $68.00 K(-5.6%) | $291.00 K(-2.3%) |
| Mar 2020 | - | $72.00 K(-4.0%) | $298.00 K(-2.0%) |
| Dec 2019 | $304.00 K | $75.00 K(-1.3%) | $304.00 K(-1.3%) |
| Sept 2019 | - | $76.00 K(+1.3%) | $308.00 K(-1.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2019 | - | $75.00 K(-3.8%) | $311.00 K(-2.5%) |
| Mar 2019 | - | $78.00 K(-1.3%) | $319.00 K(-1.5%) |
| Dec 2018 | $324.00 K(-3.6%) | $79.00 K(0.0%) | $324.00 K(-1.8%) |
| Sept 2018 | - | $79.00 K(-4.8%) | $330.00 K(-2.4%) |
| June 2018 | - | $83.00 K(0.0%) | $338.00 K(-0.3%) |
| Mar 2018 | - | $83.00 K(-2.4%) | $339.00 K(+0.9%) |
| Dec 2017 | $336.00 K(+92.0%) | $85.00 K(-2.3%) | $336.00 K(+2.1%) |
| Sept 2017 | - | $87.00 K(+3.6%) | $329.00 K(+15.8%) |
| June 2017 | - | $84.00 K(+5.0%) | $284.00 K(+24.0%) |
| Mar 2017 | - | $80.00 K(+2.6%) | $229.00 K(+30.9%) |
| Dec 2016 | $175.00 K(+108.3%) | $78.00 K(+85.7%) | $175.00 K(+45.8%) |
| Sept 2016 | - | $42.00 K(+44.8%) | $120.00 K(+21.2%) |
| June 2016 | - | $29.00 K(+11.5%) | $99.00 K(+10.0%) |
| Mar 2016 | - | $26.00 K(+13.0%) | $90.00 K(+7.1%) |
| Dec 2015 | $84.00 K(+12.0%) | $23.00 K(+9.5%) | $84.00 K(+5.0%) |
| Sept 2015 | - | $21.00 K(+5.0%) | $80.00 K(+3.9%) |
| June 2015 | - | $20.00 K(0.0%) | $77.00 K(+1.3%) |
| Mar 2015 | - | $20.00 K(+5.3%) | $76.00 K(+1.3%) |
| Dec 2014 | $75.00 K(+10.3%) | $19.00 K(+5.6%) | $75.00 K(+33.9%) |
| Sept 2014 | - | $18.00 K(-5.3%) | $56.00 K(+47.4%) |
| June 2014 | - | $19.00 K(0.0%) | $38.00 K(+100.0%) |
| Mar 2014 | - | $19.00 K | $19.00 K |
| Dec 2013 | $68.00 K | - | - |
FAQ
- What is Zevra Therapeutics annual depreciation & amortization?
- What is the all time high annual D&A for Zevra Therapeutics?
- What is Zevra Therapeutics annual D&A year-on-year change?
- What is Zevra Therapeutics quarterly depreciation & amortization?
- What is the all time high quarterly D&A for Zevra Therapeutics?
- What is Zevra Therapeutics quarterly D&A year-on-year change?
- What is Zevra Therapeutics TTM depreciation & amortization?
- What is the all time high TTM D&A for Zevra Therapeutics?
- What is Zevra Therapeutics TTM D&A year-on-year change?
What is Zevra Therapeutics annual depreciation & amortization?
The current annual D&A of ZVRA is $1.01 M
What is the all time high annual D&A for Zevra Therapeutics?
Zevra Therapeutics all-time high annual depreciation & amortization is $1.01 M
What is Zevra Therapeutics annual D&A year-on-year change?
Over the past year, ZVRA annual depreciation & amortization has changed by +$62.00 K (+6.57%)
What is Zevra Therapeutics quarterly depreciation & amortization?
The current quarterly D&A of ZVRA is $1.62 M
What is the all time high quarterly D&A for Zevra Therapeutics?
Zevra Therapeutics all-time high quarterly depreciation & amortization is $1.62 M
What is Zevra Therapeutics quarterly D&A year-on-year change?
Over the past year, ZVRA quarterly depreciation & amortization has changed by +$1.55 M (+2508.06%)
What is Zevra Therapeutics TTM depreciation & amortization?
The current TTM D&A of ZVRA is $5.53 M
What is the all time high TTM D&A for Zevra Therapeutics?
Zevra Therapeutics all-time high TTM depreciation & amortization is $5.53 M
What is Zevra Therapeutics TTM D&A year-on-year change?
Over the past year, ZVRA TTM depreciation & amortization has changed by +$5.01 M (+965.13%)